Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Issue : June 2005

View all stories from this issue.

Sort By: Newest firstOldest firstA-ZZ-A

  • The practice implications of cardiovascular risks in NSAIDsSubscription

    Clinical28 June, 2005

    Non-steroidal anti-inflammatory drugs (NSAIDs) are recognised as effective analgesics and are used in acute and chronic pain (Bandolier, 2005). However, doubts have recently emerged over the safety profile of these commonly used medications.

  • Improving the management of postoperative pain.Subscription

    Clinical28 June, 2005

    In 1997 the Audit Commission proposed a standard that fewer than 20 per cent of patients should experience severe pain after surgery, ideally reducing to fewer than five per cent by 2002 (Audit Commission, 1997).

  • Brief interventions for alcohol problems in hospital settingsSubscription

    Clinical28 June, 2005

    VOL: 101, ISSUE: 26, PAGE NO: 38

  • Role modelling as a teaching method for student mentors.Subscription

    Clinical28 June, 2005

    Nurses, midwives and health visitors are under increasing pressure due to overwork and stress, which is compounded by the need to maintain standards of care (Allen, 2001). In addition to their clinical roles, they have a duty to facilitate student nurses’ development.

  • Chronic disease management for patients with respiratory diseaseSubscription

    Clinical21 June, 2005

    VOL: 101, ISSUE: 25, PAGE NO: 46 Elisabeth Bryant, BSc, RGN, Nurse Practitioner Diploma, CPT, is programme leader for chronic disease management, National Respiratory Training Centre, Warwick

  • Interstitial lung disease: clinical features and managementSubscription

    Clinical21 June, 2005

    Interstitial lung diseases (ILDs) or diffuse parenchymal lung diseases are terms used to describe around 200 acute and chronic lung disorders (Raghu and Brown, 2004). They are a heterogeneous group of disorders of the lower respiratory tract that are characterised by both acute and chronic inflammation and a generally irreversible and relentless process of fibrosis in the interstitium and the alveolar walls (air sacs in the lungs) (Riches et al, 2003).

  • Reducing the risk of injuries to staff from insulin pensSubscription

    Clinical21 June, 2005

    It is estimated that 100,000 needlestick injuries occur each year in the UK, although it is suspected that many others go unreported (Unison, 2003). The risk of exposure to bloodborne viruses (BBV), in particular hepatitis B, hepatitis C and human immunodeficiency virus (HIV) has been documented since the mid-1980s, when the first occupational exposure and subsequent seroconversion of a health care worker to HIV positive as the result of a needlestick injury was reported (Communicable ...

  • The importance of brand continuity in epilepsy drugsSubscription

    Clinical21 June, 2005

    Epilepsy is the most common serious neurological condition and is characterised by the recurrence of epileptic seizures (Sander and Shorvon, 1996). In the UK it is estimated that as many as 440,000 people may have epilepsy, with an average of 81 new diagnoses every day (Epilepsy Action, 2005).

  • RosaceaSubscription

    Clinical21 June, 2005

    VOL: 101, ISSUE: 25, PAGE NO: 28What is it?

  • Second-hand smoke: how damaging is it to health?Subscription

    Clinical21 June, 2005

    VOL: 101, ISSUE: 25, PAGE NO: 50

Show  10 per page20 per page50 per page